161 related articles for article (PubMed ID: 22537248)
21. Monoallelic expression in melanoma.
Silcock L; Almabrazi H; Mokrab Y; Jithesh P; Al-Hashmi M; James N; Mathew R; Mattei V; Bedognetti D; Lessi F; Temanni R; Seliger B; Al-Ali R; Marincola FM; Wang E; Tomei S
J Transl Med; 2019 Apr; 17(1):112. PubMed ID: 30953523
[TBL] [Abstract][Full Text] [Related]
22. Genomic organization, incidence, and localization of the SPAN-x family of cancer-testis antigens in melanoma tumors and cell lines.
Westbrook VA; Schoppee PD; Diekman AB; Klotz KL; Allietta M; Hogan KT; Slingluff CL; Patterson JW; Frierson HF; Irvin WP; Flickinger CJ; Coppola MA; Herr JC
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):101-12. PubMed ID: 14734458
[TBL] [Abstract][Full Text] [Related]
23. Identification of differentially expressed mRNA transcripts in drug-resistant versus parental human melanoma cell lines.
Tanic N; Brkic G; Dimitrijevic B; Dedovic-Tanic N; Gefen N; Benharroch D; Gopas J
Anticancer Res; 2006; 26(3A):2137-42. PubMed ID: 16827156
[TBL] [Abstract][Full Text] [Related]
24. A new melanoma antigen fatty acid-binding protein 7, involved in proliferation and invasion, is a potential target for immunotherapy and molecular target therapy.
Goto Y; Matsuzaki Y; Kurihara S; Shimizu A; Okada T; Yamamoto K; Murata H; Takata M; Aburatani H; Hoon DS; Saida T; Kawakami Y
Cancer Res; 2006 Apr; 66(8):4443-9. PubMed ID: 16618771
[TBL] [Abstract][Full Text] [Related]
25. Applications of genomics in melanoma oncogene discovery.
Berger MF; Garraway LA
Hematol Oncol Clin North Am; 2009 Jun; 23(3):397-414, vii. PubMed ID: 19464593
[TBL] [Abstract][Full Text] [Related]
26. Long-Term Vemurafenib Exposure Induced Alterations of Cell Phenotypes in Melanoma: Increased Cell Migration and Its Association with EGFR Expression.
Molnár E; Garay T; Donia M; Baranyi M; Rittler D; Berger W; Tímár J; Grusch M; Hegedűs B
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514305
[TBL] [Abstract][Full Text] [Related]
27. Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity.
Hartman ML; Sztiller-Sikorska M; Gajos-Michniewicz A; Czyz M
Cells; 2020 Jan; 9(1):. PubMed ID: 31936151
[TBL] [Abstract][Full Text] [Related]
28. SOX5 is involved in balanced MITF regulation in human melanoma cells.
Kordaß T; Weber CE; Oswald M; Ast V; Bernhardt M; Novak D; Utikal J; Eichmüller SB; König R
BMC Med Genomics; 2016 Feb; 9():10. PubMed ID: 26927636
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation.
Kundu A; Quirit JG; Khouri MG; Firestone GL
Mol Carcinog; 2017 Jan; 56(1):49-61. PubMed ID: 26878440
[TBL] [Abstract][Full Text] [Related]
30. A genomic screen identifies TYRO3 as a MITF regulator in melanoma.
Zhu S; Wurdak H; Wang Y; Galkin A; Tao H; Li J; Lyssiotis CA; Yan F; Tu BP; Miraglia L; Walker J; Sun F; Orth A; Schultz PG; Wu X
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17025-30. PubMed ID: 19805117
[TBL] [Abstract][Full Text] [Related]
31. Genetic and epigenetic alterations of the APC gene in malignant melanoma.
Worm J; Christensen C; Grønbaek K; Tulchinsky E; Guldberg P
Oncogene; 2004 Jul; 23(30):5215-26. PubMed ID: 15133491
[TBL] [Abstract][Full Text] [Related]
32. Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression.
Rose AE; Poliseno L; Wang J; Clark M; Pearlman A; Wang G; Vega Y Saenz de Miera EC; Medicherla R; Christos PJ; Shapiro R; Pavlick A; Darvishian F; Zavadil J; Polsky D; Hernando E; Ostrer H; Osman I
Cancer Res; 2011 Apr; 71(7):2561-71. PubMed ID: 21343389
[TBL] [Abstract][Full Text] [Related]
33. Integrative analysis of the melanoma transcriptome.
Berger MF; Levin JZ; Vijayendran K; Sivachenko A; Adiconis X; Maguire J; Johnson LA; Robinson J; Verhaak RG; Sougnez C; Onofrio RC; Ziaugra L; Cibulskis K; Laine E; Barretina J; Winckler W; Fisher DE; Getz G; Meyerson M; Jaffe DB; Gabriel SB; Lander ES; Dummer R; Gnirke A; Nusbaum C; Garraway LA
Genome Res; 2010 Apr; 20(4):413-27. PubMed ID: 20179022
[TBL] [Abstract][Full Text] [Related]
34. Gene expression signatures as a guide to treatment strategies for in-transit metastatic melanoma.
Augustine CK; Jung SH; Sohn I; Yoo JS; Yoshimoto Y; Olson JA; Friedman HS; Ali-Osman F; Tyler DS
Mol Cancer Ther; 2010 Apr; 9(4):779-90. PubMed ID: 20371714
[TBL] [Abstract][Full Text] [Related]
35. Potential Prognostic Predictors and Molecular Targets for Skin Melanoma Screened by Weighted Gene Co-expression Network Analysis.
Chen S; Liu Z; Li M; Huang Y; Wang M; Zeng W; Wei W; Zhang C; Gong Y; Guo L
Curr Gene Ther; 2020; 20(1):5-14. PubMed ID: 32416689
[TBL] [Abstract][Full Text] [Related]
36. CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis.
Güre AO; Stockert E; Arden KC; Boyer AD; Viars CS; Scanlan MJ; Old LJ; Chen YT
Int J Cancer; 2000 Mar; 85(5):726-32. PubMed ID: 10699956
[TBL] [Abstract][Full Text] [Related]
37. Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.
Saunus JM; Quinn MC; Patch AM; Pearson JV; Bailey PJ; Nones K; McCart Reed AE; Miller D; Wilson PJ; Al-Ejeh F; Mariasegaram M; Lau Q; Withers T; Jeffree RL; Reid LE; Da Silva L; Matsika A; Niland CM; Cummings MC; Bruxner TJ; Christ AN; Harliwong I; Idrisoglu S; Manning S; Nourse C; Nourbakhsh E; Wani S; Anderson MJ; Fink JL; Holmes O; Kazakoff S; Leonard C; Newell F; Taylor D; Waddell N; Wood S; Xu Q; Kassahn KS; Narayanan V; Taib NA; Teo SH; Chow YP; kConFab ; Jat PS; Brandner S; Flanagan AM; Khanna KK; Chenevix-Trench G; Grimmond SM; Simpson PT; Waddell N; Lakhani SR
J Pathol; 2015 Nov; 237(3):363-78. PubMed ID: 26172396
[TBL] [Abstract][Full Text] [Related]
38. Genomic profiling of invasive melanoma cell lines by array comparative genomic hybridization.
Koroknai V; Ecsedi S; Vízkeleti L; Kiss T; Szász I; Lukács A; Papp O; Ádány R; Balázs M
Melanoma Res; 2016 Apr; 26(2):100-7. PubMed ID: 26656572
[TBL] [Abstract][Full Text] [Related]
39. BPTF transduces MITF-driven prosurvival signals in melanoma cells.
Dar AA; Majid S; Bezrookove V; Phan B; Ursu S; Nosrati M; De Semir D; Sagebiel RW; Miller JR; Debs R; Cleaver JE; Kashani-Sabet M
Proc Natl Acad Sci U S A; 2016 May; 113(22):6254-8. PubMed ID: 27185926
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
Fröhlich A; Loick S; Bawden EG; Fietz S; Dietrich J; Diekmann E; Saavedra G; Fröhlich H; Niebel D; Sirokay J; Zarbl R; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D
EBioMedicine; 2020 Feb; 52():102647. PubMed ID: 32028068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
